Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Allo-HSCT mitigates the prognostic differences between bZIP and non-bZIP CEBPA mutations in AML: A long-term follow-up study of lu daopei hospital

Yanli Zhao, Yue Lu, Deyan Liu, Jian-Ping Zhang, Zhijie Wei, Xingyu Cao, Ruijuan Sun, Min Xiong, Jiarui Zhou, Jing Long, Tong Wang, Hongxing Liu, Peihua Lu

Blood (2025) 146 (Supplement 1): 6049.

https://doi.org/10.1182/blood-2025-6049

Published: 2025

Journal Articles

Impact of germline and somatic TP53 mutations on allogeneic HSCT outcomes in hematologic malignancies

Xingyu Cao, Yang Zhang, Lili Yuan, Yue Lu, Jian-Ping Zhang, Zhijie Wei, Deyan Liu, Min Xiong, Yanli Zhao, Jiarui Zhou, Ruijuan Sun, Mengyuan Niu, Fangmin Pan, Jing Long, Peihua Lu

Blood (2025) 146 (Supplement 1): 7786.

https://doi.org/10.1182/blood-2025-7786

Published: 2025

Journal Articles

Allogeneic hematopoietic stem cell transplantation in sil::TAL1-positive T-ALL: Prognostic impact of pre-transplant remission and molecular status

Xiao-hong Liu, Jing Long, Jiarui Zhou, Min Xiong, Xingyu Cao, Jian-Ping Zhang, Yue Lu, Zhijie Wei, Yanli Zhao, Ruijuan Sun, Fangmin Pan, Peihua Lu, Deyan Liu

Blood (2025) 146 (Supplement 1): 2502.

https://doi.org/10.1182/blood-2025-2502

Published: 2025

Journal Articles

Optimizing letermovir timing: Day +5 to +8 post haplo-HSCT minimizes EBV dnaemia without compromising CMV prophylaxis

Xingyu Cao, Yue Lu, Jian-Ping Zhang, Zhijie Wei, Deyan Liu, Min Xiong, Yanli Zhao, Jiarui Zhou, Ruijuan Sun, Mengyuan Niu, Fangmin Pan, Jing Long, Peihua Lu

Blood (2025) 146 (Supplement 1): 2500.

https://doi.org/10.1182/blood-2025-2500

Published: 2025

Journal Articles

No reduction in gvhd risk for aplastic anemia patients to combined third-party unrelated cord blood in haploidentical hematopoietic stem cells transplantation

Wei Zhao, Xingyu Cao, Yue Lu, Jian-Ping Zhang, Zhijie Wei, Deyan Liu, Min Xiong, Jiarui Zhou, Ruijuan Sun, Jing Long, Peihua Lu, Yanli Zhao

Blood (2025) 146 (Supplement 1): 2495.

https://doi.org/10.1182/blood-2025-2495

Published: 2025

Journal Articles

Multi-hit TP53 mutation is an independent adverse prognostic factor in allogeneic hematopoietic stem cell transplantation for acute leukemia and myelodysplastic syndromes

Yanli Zhao, Yue Lu, Deyan Liu, Jian-Ping Zhang, Zhijie Wei, Xingyu Cao, Ruijuan Sun, Jiarui Zhou, Min Xiong, Jing Long, Tong Wang, Peihua Lu

Blood (2025) 146 (Supplement 1): 2493.

https://doi.org/10.1182/blood-2025-2493

Published: 2025

Journal Articles

Improved Survival outcomes with allo-HSCT in NUP214::ABL1-Positive Acute leukemia: A pooled analysis and single-center experience

Jiu-jiang He, Jing Long, Qian Yang, Peihua Lu, Junfang Yang

Blood (2025) 146 (Supplement 1): 4258.

https://doi.org/10.1182/blood-2025-4258

Published: 2025

Journal Articles

Long-term outcomes of allo-HSCT in SET::CAN-positive Hematological Malignancies: A 12-year single-center Study of 36 patients

Xiaomei Liu, Jing Long, Deyan Liu, Jian-Ping Zhang, Yue Lu, Zhijie Wei, Yanli Zhao, Xingyu Cao, Min Xiong, Jiarui Zhou, Ruijuan Sun, Fangmin Pan, Mengyuan Niu, Peihua Lu

Blood (2025) 146 (Supplement 1): 2482.

https://doi.org/10.1182/blood-2025-2482

Published: 2025

Journal Articles

Autologous hematopoietic stem cell transplantation followed by CD19/CD22 dual-target CAR-T therapy for refractory or relapsed burkitt lymphoma

Xian Zhang, Lin Wang, Xiangqun Li, Jing Long, Peihua Lu

Blood (2025) 146 (Supplement 1): 5924.

https://doi.org/10.1182/blood-2025-5924

Published: 2025

Journal Articles

CD3⁺cell dose is an independent risk factor for grade II–IV aGVHD following cord blood transplantation in children with aplastic anemia

Jian-Ping Zhang, Li Nannan, Min Xiong, Jing Long, Xingyu Cao, Yue Lu, Zhijie Wei, Deyan Liu, Ruijuan Sun, Jiarui Zhou, Yanli Zhao, Jun-bao He, Peihua Lu

Blood (2025) 146 (Supplement 1): 7752.

https://doi.org/10.1182/blood-2025-7752

Published: 2025

Journal Articles

A Long-Term Follow-up Retrospective Study of the Clinical Efficacy of Haploidentical Hematopoietic Stem Cell Transplantation for Early T-Precursor Acute Lymphoblastic Leukemia and T-Lymphoblastic Lymphoma

Xingyu Cao, Yue Lu, Jian-Ping Zhang, Deyan Liu, Zhijie Wei, Yanli Zhao, Jiarui Zhou, Min Xiong, Ruijuan Sun, Jing Long, Peihua Lu

Blood (2024) 144 (Supplement 1): 4934.

https://doi.org/10.1182/blood-2024-204579

Published: 2024

Journal Articles

Improved Outcomes with Bu/Cy+Melphalan and Bu/Cy+Thiotepa Regimens in Haploidentical Hematopoietic Stem Cell Transplantation for Non-Down Syndrome Acute Megakaryoblastic Leukemia

Zhijie Wei, Fei Pan, Jing Long, Guanlan Yue, Kang Gao, Kun Wang, Huili Zhu, Yujie Wang, Zheren Wang, Peihua Lu

Blood (2024) 144 (Supplement 1): 3492.

https://doi.org/10.1182/blood-2024-206814

Published: 2024

Journal Articles

Prophylactic Basiliximab on Days +1 and +4 Post-Haploidentical Hematopoietic Stem Cell Transplantation Reduces Incidence of Grade II-IV Acute Graft-Versus-Host Disease in Acute Myeloid Leukemia Patients in Complete Remission (M1, M2, and M4 Subtypes)

Zhijie Wei, Fei Pan, Jing Long, Zheren Wang, Guanlan Yue, Kang Gao, Kun Wang, Huili Zhu, Yujie Wang, Peihua Lu

Blood (2024) 144 (Supplement 1): 7363.

https://doi.org/10.1182/blood-2024-206773

Published: 2024

Update search

NARROW

Publications

Format

Article Type

Date

Availability

Allo-HSCT mitigates the prognostic differences between bZIP and non-bZIP CEBPA mutations in AML: A long-term follow-up study of lu daopei hospital

Impact of germline and somatic TP53 mutations on allogeneic HSCT outcomes in hematologic malignancies

Allogeneic hematopoietic stem cell transplantation in sil::TAL1-positive T-ALL: Prognostic impact of pre-transplant remission and molecular status

Optimizing letermovir timing: Day +5 to +8 post haplo-HSCT minimizes EBV dnaemia without compromising CMV prophylaxis

No reduction in gvhd risk for aplastic anemia patients to combined third-party unrelated cord blood in haploidentical hematopoietic stem cells transplantation

Multi-hit TP53 mutation is an independent adverse prognostic factor in allogeneic hematopoietic stem cell transplantation for acute leukemia and myelodysplastic syndromes

Improved Survival outcomes with allo-HSCT in NUP214::ABL1-Positive Acute leukemia: A pooled analysis and single-center experience

Long-term outcomes of allo-HSCT in SET::CAN-positive Hematological Malignancies: A 12-year single-center Study of 36 patients

Autologous hematopoietic stem cell transplantation followed by CD19/CD22 dual-target CAR-T therapy for refractory or relapsed burkitt lymphoma

CD3⁺cell dose is an independent risk factor for grade II–IV aGVHD following cord blood transplantation in children with aplastic anemia

A Long-Term Follow-up Retrospective Study of the Clinical Efficacy of Haploidentical Hematopoietic Stem Cell Transplantation for Early T-Precursor Acute Lymphoblastic Leukemia and T-Lymphoblastic Lymphoma

Improved Outcomes with Bu/Cy+Melphalan and Bu/Cy+Thiotepa Regimens in Haploidentical Hematopoietic Stem Cell Transplantation for Non-Down Syndrome Acute Megakaryoblastic Leukemia

Prophylactic Basiliximab on Days +1 and +4 Post-Haploidentical Hematopoietic Stem Cell Transplantation Reduces Incidence of Grade II-IV Acute Graft-Versus-Host Disease in Acute Myeloid Leukemia Patients in Complete Remission (M1, M2, and M4 Subtypes)

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only